NUTRA PHARMA CORP (NPHC) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $12.2K | -66.6% |
| 2024 | $36.4K | — |
| 2023 | $0 | — |
| 2022 | $0 | — |
| 2014 | $15.5K | +234.7% |
| 2013 | $4.6K | -38.6% |
| 2012 | $7.6K | — |
| 2011 | $0 | — |
| 2010 | $0 | -100.0% |
| 2009 | $802.9K | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $12.2K | -66.6% |
| 2024 | $36.4K | — |
| 2023 | $0 | — |
| 2022 | $0 | — |
| 2014 | $15.5K | +234.7% |
| 2013 | $4.6K | -38.6% |
| 2012 | $7.6K | — |
| 2011 | $0 | — |
| 2010 | $0 | -100.0% |
| 2009 | $802.9K | — |